You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 18 No. 3, March 1968 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Lack of Some Muscle Proteins in Serum of Patients With Duchenne Dystrophy

Lewis P. Rowland, MD; Robert B. Layzer, MD; Lawrence J. Kagen, MD

Arch Neurol. 1968;18(3):272-276.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AN'abnormal increase in the activity of several serum enzymes is one clue to the nature of the biochemical abnormality in Duchenne muscular dystrophy. The increased serum enzyme activity is thought to occur because enzyme protein molecules are released from muscle, and it has been inferred that the fundamental disorder is an abnormality of the muscle membrane which permits pathological leakage of large molecules. If this were true, it might be expected that other cytoplasmic constituents of muscle would also be found in the serum.

We have been studying phosphofructokinase (PFK), phosphorylase (PPL), and myoglobin in normal human muscle diseases. Appropriate techniques were applied to the serum of patients with Duchenne dystrophy but PFK and myoglobin were not found at all and the activities of PPL were very low, as will be described in detail.

Methods

The patients were all ambulatory males below age 10 years, with overt manifestations of . . . [Full Text PDF of this Article]


Author Affiliations

New York

From the departments of neurology and medicine, College of Physicians and Surgeons, Columbia University, and the Neurological Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center, New York. Dr. Rowland is not at the Hospital of the University of Pennsylvania, Philadelphia. Dr. Layzer is now at the University of California School of Medicine, San Francisco.


Footnotes

Submitted for publication Aug 24, 1967; accepted Oct. 6.

Reprint requests to 3400 Spruce St, Philadelphia 19104 (Dr. Rowland).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.